Aeglea BioTherapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, Jan. 4, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeut…